Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma
Conditions
- Brain and Central Nervous System Tumors
Interventions
- DRUG: hydroxyurea
- DRUG: imatinib mesylate
- DRUG: vatalanib
Sponsor
Duke University
Collaborators